Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−301.80 USD
−11.21 M USD
43.00 K USD
550.74 K
About Bio Green Med Solution, Inc.
Sector
Industry
CEO
Sing Ee Wong
Website
Headquarters
Berkeley Heights
Founded
1996
ISIN
US23254L8761
FIGI
BBG000CT3XM2
Bio Green Med Solution, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. It operates through the United States and United Kingdom geographical segments. The company builds a biopharmaceutical business, which is focused on hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on January 5, 1996 and is headquartered in Berkeley Heights, NJ.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BOATS exchange Bio Green Med Solution, Inc. stocks are traded under the ticker BGMS.
Yes, you can track Bio Green Med Solution, Inc. financials in yearly and quarterly reports right on TradingView.
Bio Green Med Solution, Inc. is going to release the next earnings report on Nov 18, 2025. Keep track of upcoming events with our Earnings Calendar.
BGMS earnings for the last quarter are −0.98 USD per share, whereas the estimation was −72.00 USD resulting in a 98.64% surprise. The estimated earnings for the next quarter are −72.00 USD per share. See more details about Bio Green Med Solution, Inc. earnings.
BGMS net income for the last quarter is −1.32 M USD, while the quarter before that showed −81.00 K USD of net income which accounts for −1.53 K% change. Track more Bio Green Med Solution, Inc. financial stats to get the full picture.
No, BGMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bio Green Med Solution, Inc. EBITDA is −10.35 M USD, and current EBITDA margin is −36.54 K%. See more stats in Bio Green Med Solution, Inc. financial statements.
Like other stocks, BGMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bio Green Med Solution, Inc. stock right from TradingView charts — choose your broker and connect to your account.